Voldřich Richard, Charvát František, Netuka David
Department of Neurosurgery and Neurooncology, Military University Hospital, Charles University, First Faculty of Medicine in Prague, Prague, Czech Republic.
Department of Radiology, Military University Hospital, Prague, Czech Republic.
Interv Neuroradiol. 2024 Jan 3:15910199231217549. doi: 10.1177/15910199231217549.
While coiling is considered the standard treatment for carotid-cavernous fistulas (CCFs), studies demonstrating excellent results using new materials, especially flow diverter (FD) stents and liquid embolisates, are becoming more frequent. The indications and effectiveness of these alternative endovascular techniques remain unclear.
A total of 22 direct and 20 indirect CCFs were included in the study. These were further subdivided based on the embolic material used: coils versus FD stents for direct and coils versus liquid embolisates for indirect CCFs. The subgroups were subjected to statistical analysis.
An angiographic cure was achieved in 88% of all CCFs, 93% of patients' experienced clinical improvement or remained stable. Direct CCFs were treated with coiling (41%) or with both coils and FD stents (55%). One (4%) patient with a direct CCF was treated with FD stent alone. Statistical analysis comparing these subgroups revealed a significantly higher complete occlusion rate immediately after treatment in the coiling subgroup (67% vs. 23%, = 0.0409). The occlusion rates at the last follow-up were similar (89% vs. 85%). Indirect CCFs were treated with coiling (35%) or liquid embolisates (65%). All three periprocedural ischemic complications were recorded within the liquid subgroup, resulting in a significantly higher clinical deterioration rate ( = 0.0333).
FD stents in direct and liquid embolisates in indirect fistulas did not demonstrate better angiographic or clinical outcomes compared to convetional coiling. Liquid agents carried a higher risk of ischemic complications. Alternative embolization materials should be reserved for CCFs that cannot be treated with simple coiling.
虽然血管内栓塞术被认为是治疗颈内动脉海绵窦瘘(CCF)的标准方法,但使用新材料(尤其是血流导向(FD)支架和液体栓塞剂)且显示出优异效果的研究日益增多。这些替代性血管内技术的适应症和有效性仍不明确。
本研究共纳入22例直接型和20例间接型CCF。根据所使用的栓塞材料进一步细分:直接型CCF分为使用弹簧圈与FD支架,间接型CCF分为使用弹簧圈与液体栓塞剂。对各亚组进行统计分析。
所有CCF中88%实现血管造影治愈,93%的患者病情改善或保持稳定。直接型CCF采用单纯弹簧圈栓塞治疗(41%)或弹簧圈与FD支架联合治疗(55%)。1例(4%)直接型CCF患者仅接受FD支架治疗。比较这些亚组的统计分析显示,弹簧圈栓塞亚组治疗后即刻的完全闭塞率显著更高(67%对23%,P = 0.0409)。末次随访时的闭塞率相似(89%对85%)。间接型CCF采用弹簧圈栓塞治疗(35%)或液体栓塞剂治疗(65%)。所有3例围手术期缺血性并发症均发生在液体栓塞剂亚组,导致临床恶化率显著更高(P = 0.0333)。
与传统弹簧圈栓塞相比,直接型CCF使用FD支架和间接型CCF使用液体栓塞剂并未显示出更好的血管造影或临床结果。液体栓塞剂存在更高的缺血性并发症风险。替代性栓塞材料应仅用于无法通过单纯弹簧圈栓塞治疗的CCF。